09262017Headline:

Oklahoma City, Oklahoma

HomeOklahomaOklahoma City

Email Guest Author
Guest Author
Guest Author
Contributor •

SSRI Usage During Pregnancy Linked to Increase Risk for Neonatal Pulmonary Hypertension

Comments Off

WebMD just released a report stating

"Pregnant women who use certain popular antidepressants may have a twofold increased risk for delivering babies with a rare but serious lung disorder, a new study finds."

The release notes that researchers

"analyzed national registry data from 1.6 million births in five Nordic countries in an effort to determine if using selective serotonin reuptake inhibitor (SSRI) antidepressants during pregnancy raises the risk for neonatal pulmonary hypertension, a life-threatening condition in newborns that normally occurs in one to two births in 1,000."

The Mayo clinic notes that SSRIs (selective serotonin reuptake inhibitors) are commonly prescribed antidepressants for treatment of moderate to severe depression. SSRIs ease depression by affecting chemical messengers (neurotransmitters) used to communicate between brain cells. Popular SSRI medications include Paxil, Lexapro, Zoloft, Celexa and Prozac.

McIntyre Law has been a leader in SSRI birth defect litigation for many years. We will continue to investigate whether neonatal pulmonary hypertension has a casual relationship with SSRI use during pregnancy and if so, avail our current and future clients to their full rights under law.